
Rotavirus surge in the US spotlights vaccination gaps
CDC data show a rise in US rotavirus infections, with 7.3% of tests positive in the week ending April 4 (last year’s peak was 6.77%), likely tied to declining vaccination rates post-COVID and a post-pandemic rebound. With no antiviral treatment, prevention hinges on completing the rotavirus vaccine series (Rotateq and Rotarix) and ongoing hygiene; severe cases require IV rehydration and supportive care, especially for infants and young children.













